DEHP-plasticised PVC: relevance to blood services

Area of Science:

• Toxicology
• Plasticizer Chemistry
• Transfusion Medicine

Background:

• Phthalates, including Di(2-ethylhexyl)phthalate (DEHP), are widely used plasticizers in medical applications since 1955.
• DEHP is a common component in blood bags and tubing sets, raising concerns about potential health effects.
• Existing studies on DEHP exposure effects, particularly intravenous exposure, are limited in higher mammals and humans.

Purpose of the Study:

• To review the toxicology of Di(2-ethylhexyl)phthalate (DEHP).
• To evaluate the safety and benefits of DEHP in transfusion medicine.
• To explore alternatives to DEHP and examine regulatory landscapes.

Main Methods:

• Literature review on DEHP toxicology and its use in medical devices.
• Analysis of environmental and health concerns related to DEHP exposure.
• Examination of international and European regulatory recommendations and their impact.

Main Results:

• Concerns exist regarding DEHP's potential adverse effects, though direct evidence from intravenous exposure studies is scarce.
• DEHP offers benefits in medical applications, but alternative plasticizers are being explored.
• Legislation and regulatory recommendations are influencing the use of DEHP in transfusion medicine and medical devices.

Conclusions:

• A comprehensive understanding of DEHP toxicology is crucial for transfusion medicine.
• Balancing the benefits of DEHP with potential risks and regulatory requirements is essential.
• The medical device and blood industries must adapt to evolving regulations concerning DEHP use.